Gender Male
Dr. Nagy generated Canada’s first embryonic stem cell lines and discovered the first efficient non-viral method to reprogram somatic cells in to iPSCs. He was among the first who discovered the “dark side” of stem cell generation by finding that the establishment of these cells are associated with genetic damage. This discovery lead him to focus
on finding a way to eliminate the potential risk of tumor formation if stem cell derived therapeutic cells are used in patients. He is a Canada Research Chair in Stem Cells and Regeneration as well as a senior scientific investigator at the Lunenfeld-Tanenbaum Research Institute, Sinai Health System and a Professor in the Department of Obstetrics & Gynaecology and Institute of Medical Science at the University of Toronto. Dr. Nagy is also a Professor at the Monash University, Melbourne, Australia and runs a second laboratory in the Australian Regenerative Medicine Institute (ARMI)